Delivery Order SPE2DB22D3501-SPE2DB25FXM39
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/8 mL vials with a ceiling value of $1,314.60. This delivery order, issued on September 11, 2025, represents a firm fixed-price procurement executed without any set-aside designation, indicating competitive award to the contractor based on open competition. The product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $4,041.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Docetaxel 160 mg/16 ml vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive set-aside delivery order represents a pharmaceutical supply transaction fulfilling military healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $6,356.57 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Docetaxel 160 mg/16 ml vials. This award represents a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,574.73 for Docetaxel 160 mg/16 mL vials on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Docetaxel is a chemotherapy medication used primarily in cancer treatment protocols across military and federal...
- This is a $7,315.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 160 mg/16 ml vials of the cancer medication docetaxel. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $54,620 under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is to provide 160 mg/8 ml vials of the chemotherapy drug docetaxel for the period of August 28-29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply needs of the U.S. military...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 160 mg/16 ml vials of the medication Docetaxel, a chemotherapy drug. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $3,916.80 and a period of performance through May 8, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,402.12 firm fixed-price delivery order is for the supply of 80 mg/4 ml vials of the chemotherapy drug docetaxel. The contract has an ultimate completion date of October 13, 2022 and was awarded on October 12, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXM39Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,434.04 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 ml vials on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract covers the delivery of this pharmaceutical product to support federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the pharmaceutical distributor to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support global military healthcare programs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp has demonstrated capability to fulfill diverse medical supply requirements through multiple competitively awarded contracts with the Defense Logistics Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/23/25 |